The relationship between visible thrombus aspiration material with no-reflow and in-hospital mortality ratio in patients with anterior ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

Şeker T., TÜRKOĞU C., akkus o., GÜR M.

Türk Kardiyoloji Derneği Arşivi, cilt.47, sa.2, ss.95-102, 2019 (Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5543/tkda.2019.49940
  • Dergi Adı: Türk Kardiyoloji Derneği Arşivi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.95-102
  • Hatay Mustafa Kemal Üniversitesi Adresli: Evet

Özet

Objective: The benefit of intracoronary thrombus aspiration(TA) during primary percutaneous coronary intervention(pPCI) in patients with ST-segment elevation myocardial infarction(STEMI) is not yet fully clear. The aim of this studywas to investigate the clinical impact of visible thrombus aspiration(VTA) material.Methods: A total of 295 patients with a Thrombolysis in MyocardialInfarction (TIMI) flow score of 0 or 1 after an anteriorSTEMI were included in the study. Manual TA devices wereused before performing PCI. The patients were divided into2 groups: (1) visible thrombus aspiration (VTA) group and (2)non-visible thrombus aspiration (non-VTA) group. No-reflowwas defined as TIMI grade 0, 1, or 2 flow, or TIMI grade 3 witha myocardial blush of grade 0 or 1. The primary endpoint wasthe occurrence of no-reflow.Results: VTA was retrieved in 178 (60.3%) of the patients. Ano-reflow determination was significantly less frequent in theVTA group (p<0.001). The ejection fraction and ST-segmentresolution values were higher, and the in-hospital mortality,Killip class II-IV rating, and post-pPCI TIMI frame count werelower in the VTA group (p<0.05 for each).Conclusion: VTA predicted a lower rate of in-hospital mortalityand no-reflow in patients with anterior STEMI who underwentpPCI.